Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2

Gene Expression

Volumn 13, Issue 6, 2007, Pages 339-351

  Botta, Annalisa ^a   Vallo, Laura ^a   Rinaldi, Fabrizio ^a   Bonifazi, Emanuela ^b   Amati, Francesca ^a   Biancolella, Michela ^a   Gambardella, Stefano ^a   Mancinelli, Enzo ^c   Angelini, Corrado ^d   Meola, Giovanni ^c   Novelli, Giuseppe ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Expression analysis; Ion channels; Myotonic dystrophy; Pathogenesis; Splicing

Indexed keywords

BINDING PROTEIN; CALCIUM; CHLORIDE CHANNEL; INSULIN RECEPTOR; MESSENGER RNA; POTASSIUM; PROTEIN CUGBP1; PROTEIN MBNL1; PROTEIN MTMR1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM METABOLISM; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MUSCLE BIOPSY; MYOTONIC DYSTROPHY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POTASSIUM METABOLISM; RNA SPLICING;

ADULT; ALTERNATIVE SPLICING; BIOPSY; CHLORIDE CHANNELS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HUMANS; ION CHANNELS; MALE; MUSCLES; MYOTONIC DYSTROPHY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION;

EID: 34548072824     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006781510705     Document Type: Article

References (61)

1. Alekov, A.; Rahman, M. M.; Mitrovic, N.; Lehmann-Horn, F.; Lerche, H. A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. J. Physiol. 529:533-539; 2000.
2. Benders, A. A. G. M.; Wevers, R. A.; Veerkamp, J. H. Ion transport in human skeletal muscle cells: Disturbances in myotonic dystrophy and Brody's disease. Acta Physiol. Scand. 156:355-367; 1996.
3. 2+ homeostasis in skeletal muscle cells. J. Clin. Invest. 100:1440-1447; 1997.
4. Bonifazi, E.; Vallo, L.; Giardina, E.; Botta, A.; Novelli, G. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn. Mol. Pathol. 13:164-166; 2004.
5. Botta, A.; Caldarola, S.; Vallo, L.; Bonifazi, E.; Fruci, D.; Gullotta, F.; Massa, R.; Novelli, G.; Loreni, F. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Biochim. Biophys. Acta 1762:329-334; 2006.
6. Brook, J. D.; McCurrach, M. E.; Harley, H. G.; Buckler, A. J.; Church, D.; Aburatani, H.; Hunter, K.; Stanton, V. P.; Thirion, J. P.; Hudson, T.; et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808; 1992.
7. Buj-Bello, A.; Furling, D.; Tronchere, H.; La Porte, J.; Lerouge, T.; Butler-Browne, G. S.; Mandle, J. L. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 11:2297-2307; 2002.
8. Carango, P.; Noble, J. E.; Marks, H. G.; Funanage, V. L. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 18:340-348; 1993.
9. Charlet, B. N.; Savkur, R. S.; Singh, G.; Philips, A. V.; Grice, E. A.; Cooper, T. A. Loss of the muscle-specific chloride channel in type1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10:45-53; 2002.
10. Day, J. W.; Roelefs, R.; Leroy, B.; Pech, I.; Benzow, K.; Ranum, L. P. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul. Disord. 9:19-27; 1999.
11. Day, J. W.; Ranum, L. P. RNA pathogenesis of the myotonic dystrophies. Neuromuscul. Disord. 15:5-16; 2005.
12. Desnuelle, C.; Lombet, A.; Serratrice, G.; Lazdunski, M. Sodium channel and sodium pump in normal and pathological muscles from patients with myotonic muscular dystrophy and lower motor neuron impairment. J. Clin. Invest. 69:358-367; 1982.
13. Doerner, A.; Pauschinger, M.; Badorff, A.; Noutsias, M.; Giessen, S.; Schulze, K.; Bilger, J.; Rauch, U.; Schultheiss, H. P. Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett. 414:258-262; 1997.
14. Dunne, P. W.; Walch, E. T.; Epstein, H. F. Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition. Biochemistry 33:10809-10814; 1994.
15. Ebralidze, A.; Wang, Y.; Petkova, V.; Ebralidse, R.; Junhans, R. P. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303:383-387; 2004.
16. Edstrom, L.; Wroblewski, R. Intracellular elemental composition of single muscle fibres in muscular dystrophy and dystrophia myotonica. Acta Neurol. Scand. 80:419-424; 1989.
17. Fardaei, M.; Larkin, K.; Brook, J. D.; Hamshere, M. G. In vivo colocalisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 29:2766-2771; 2001.
18. Fardaei, M.; Rogers, M. T.; Thorpe, H. M.; Larkin, K.; Hamshere, M. G.; Harper, P. S.; Brook, J. D. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1and DM2 cells. Hum. Mol. Genet. 11:805-814; 2002.
19. - conductance in resealed muscle fibre segments from patients with myotonic dystrophy. J. Physiol. 425:391-405; 1990.
20. Fu, Y. H.; Pizzuti, A.; Fenwick, Jr., R. G.; King, J.; Rajnarayan, S.; Dunne, P. W.; Dubel, J.; Nasser, G. A.; Ashizawa, T.; De Jong, P.; et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-1258; 1992.
21. Fu, Y. H.; Friedman, D. L.; Richards, S.; Pearlman, J. A.; Gibbs, R. A.; Pizzuti, A.; Ashizawa, T.; Perryman, M. B.; Scarlato, G.; Fenwick, Jr., R. G.; et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260:235-238; 1993.
22. Gennarelli, M.; Pavoni, M.; Amicucci, P.; Novelli, G.; Dallapiccola, B. A single polymerase chain reaction protocol for detecting normal and expanded alleles in myotonic dystrophy. Diagn. Mol. Pathol. 7:135-137; 1998.
23. Gruener, R.; Stern, L. Z.; Markovitz, D.; Gerdes, C. Electrophysiologic properties of intercostal muscle fibers in human neuromuscular diseases. Muscle Nerve 2:165-172; 1979.
24. Harper, P. S. Myotonic dystrophy, 3rd ed. London: Saunders; 2001.
25. Ho, T. H.; Bundman, D.; Armstrong, D. L.; Cooper, T. A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 14:1539-1547; 2005.
26. Jacobs, A. E.; Benders, A. A.; Oosterhof, A.; Veerkamp, J. H.; van Mier, P.; Wevers, R. A.; Joosten, E. M. The calcium homeostasis and the membrane potential of cultured muscle cells from patients with myotonic dystrophy. Biochim Biophys Acta 1096:14-19; 1990.
27. Jiang, H.; Mankodi, A.; Swanson, M. S.; Moxley, R. T.; Thornton, C. A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13:3079-3088; 2004.
28. Kanadia, R. N.; Johnstone, K. A.; Mankodi, A.; Lungu, C.; Thorthon, C. A.; Esson, D.; Timmers, A. M.; Hauswirth, W. W.; Swanson, M. S. A muscleblind knockout model for myotonic dystrophy. Science 302:1978-1980; 2003.
29. Kendziorski, C.; Irizarry, R. A.; Chen, K. S.; Haag, J. D.; Gould, M. N. On the utility of pooling biological samples in microarray experiments. Proc. Natl. Acad. Sci. USA 102:4252-4257; 2005.
30. Kimura, T.; Takahashi, M. P.; Okuda, Y.; Kaido, M.; Fujimura, H.; Yanagihara, T.; Sakoda, S. The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy. Neurosci. Lett. 295:93-96; 2000.
31. 2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 14:2189-2200; 2005.
32. Ladd, A. N.; Charlet, N.; Cooper, T. A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21:1285-1296; 2001.
33. Lingrel, J. B.; Orlowski, J.; Shull, M. M.; Price, E. M. Molecular genetics of Na,K-ATPase. Prog. Nucleic Acid Res. Mol. Biol. 38:37-89; 1990.
34. Liquori, C. L.; Ricker, K.; Moseley, M. L.; Jacobsen, J. F.; Kress, W.; Naylor, S. L.; Day, J. W.; Ranum, L. P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867; 2001.
35. Lueck, J. D.; Mankodi, A.; Swanson, M. S.; Thornton, C. A.; Dirksen, R. T. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J. Gen. Physiol. 129:79-94; 2007.
36. Maduke, M.; Miller, C.; Mindell, J. A. A decade of CLC chloride channels: structure, mechanism, and many unsettled questions. Annu. Rev. Biophys. Biomol. Struct. 29:411-438; 2000.
37. Mahadevan, M.; Tsilfidis, C.; Sabourin, L.; Shutler, G.; Amemiya, C.; Jansen, G.; Neville, C.; Narang, M.; Barcelo, J.; O'Hoy, K.; et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253-1255; 1992.
38. + channel beta 1 subunit gene (SCN1B). Genomics 23:628-634; 1994.
39. Mankodi, A.; Urbinati, C. R.; Yuan, Q. P.; Moxley, R. T.; Sansone, V.; Krym, M.; Henderson, D.; Schalling, M.; Swanson, M. S.; Thornton, C. A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10:2165-2170; 2001.
40. Mankodi, A.; Takahashi, M. P.; Jiang, H.; Beck, C. L.; Bowers, W. J.; Moxley, R. T.; Cannon, S. C.; Thornton, C. A. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10:35-44; 2002.
41. Margolis, J. M.; Schoser, B. G.; Moseley, M. L.; Day, J. W.; Ranum, L. P. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum. Mol. Genet. 15:1808-1815; 2006.
42. Meola, G.; Moxley, III, R. T. Myotonic dystrophy type 2 and related myotonic disorders. J. Neurol. 251:1173-1182; 2004.
43. Miller, J. W.; Urbinati, C. R.; Teng-Umnuay, P.; Stenberg, M. G.; Byrne, B. J.; Thornton, C. A.; Swanson, M. S. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19:4439-4448; 2000.
44. Mussini, I.; Donatella, B.; Marin, O.; Furlan, S.; Salvatori, S. Myotonic dystrophy protein kinase expressed in rat cardiac muscle is associated with sarcoplasmic reticulum and gap junctions. J. Histochem. Cytochem. 47:383-392; 1999.
45. Nagamitsu, S.; Matsuura, T.; Khajavi, M.; Armstrong, R.; Gooch, C.; Harati, Y.; Ashizawa, T. A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology 55:1697-1703; 2000.
46. Osborne, R. J.; Thornton, C. A. RNA-dominant diseases. Hum. Mol. Genet. 15:R162-R169; 2006.
47. Peng, X.; Wood, C. L.; Blalock, E. M.; Chen, K. C.; Landfield, P. W.; Stromberg, A. J. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 24:4-26; 2003.
48. Philips, A. V.; Timchenko, L. T.; Cooper, T. A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280:737-741; 1998.
49. Ranum, L. P.; Rasmussen, P. F.; Benzow, K. A.; Koob, M. D.; Day, J. W. Genetic mapping of a second myotonic dystrophy locus. Nat. Genet. 19:196-198; 1998.
50. Ranum, L. P.; Day, J. W. Pathogenic RNA repeats: An expanding role in genetic disease. Trends Genet. 20:506-512; 2004.
51. Rajavashisth, T. B.; Taylor, A. K.; Andalibi, A.; Svenson, K. L.; Lusis, A. J. Identification of a zinc finger protein that binds to the sterol regulatory element. Science 245:640-643; 1989.
52. Ricker, K.; Koch, M. C.; Lehmann-Horn, F.; Pongratz, D.; Otto, M.; Heine, R.; Moxley, III, R. T. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44:1448-1452; 1994.
53. Savkur, R. S.; Philips, A. V.; Cooper, T. A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29:40-47; 2001.
54. Savkur, R. S.; Philips, A. V.; Cooper, T. A.; Dalton, J. C.; Moseley, M. L.; Ranum, L. P.; Day, J. W. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 74:1309-1313; 2004.
55. Schneider, C.; Wessig, C.; Muller, C. R.; Brechtelsbauer, D.; Grimm, T. Proximal myotonic myopathy and proximal myotonic dystrophy: Two different entities? The phenotypic variability of proximal myotonic syndromes. Neuromuscul. Disord. 11:485-488; 2001.
56. Sergeant, N.; Sablonniere, B.; Schraen-Maschke, S.; Ghestem, A.; Maurage, C. A.; Wattez, A.; Vermersch, P.; Delacourte, A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10:2143-2155; 2001.
57. Taylor, D. J.; Kemp, G. J.; Woods, C. G.; Edwards, J. H.; Radda, G. K. Skeletal muscle bioenergetics in myotonic dystrophy. J. Neurol. Sci. 116:193-200; 1993.
58. Timchenko, L. T.; Miller, J. W.; Timchenko, N. A.; De Vore, D. R.; Datar, K. V.; Lin, L.; Roberts, R.; Caskey, C. T.; Swanson, M. S. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24:4407-4414; 1996.
59. Timchenko, N. A.; Patel, R.; Iakova, P.; Cai, Z. J.; Quan, L.; Timchenko, L. T. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem. 279:13129-13139; 2004.
60. Vermersch, P.; Sergeant, N.; Ruchoux, M. M.; Hofmann-Radvanyi, H.; Wattez, A.; Petit, H.; Dwailly, P.; Delacourte, A. Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 47:711-717; 1996.
61. 2+ release from internal stores in cardiac and skeletal muscles. Acta Biochim. Pol. 47:705-723; 2000.